Literature DB >> 2968928

Monoclonal antibodies against human leucocyte antigens. II. Antibodies against CD45 (T200), CD3 (T3), CD43, CD10 (CALLA), transferrin receptor (T9), a novel broadly expressed 18-kDa antigen (MEM-43) and a novel antigen of restricted expression (MEM-74).

V Horejsí1, P Angelisová, V Bazil, H Kristofová, S Stoyanov, I Stefanová, P Hausner, M Vosecký, I Hilgert.   

Abstract

The specificities of several monoclonal antibodies described by us earlier were determined more exactly: (1) antibodies MEM-31 and MEM-32 are directed against CD8 and CD5 T cell antigens, respectively: (2) MEM-15 and MEM-18 react with the CD14 monocyte antigen; (3) MEM-28 recognizes the CD45 pan-leucocyte antigen. Several new monoclonal antibodies are described: (4) MEM-55 and MEM-58, reactive with subsets of CD45-related molecules; (5) MEM-43, recognizing a broadly expressed 18-kDa glycoprotein; (6) MEM-57, reacting with the CD3 antigen complex: (7) MEM-59 recognizing the CD43 leucocyte antigen; (8) MEM-74, which reacts with an unidentified antigen strongly expressed on several cell lines and many leukaemic cells but absent from most resting leucocytes; (9) MEM-75, directed against transferrin receptor, and (10) MEM-78, recognizing CD10 (CALLA) antigen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968928

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  9 in total

1.  Human leucocyte surface glycoprotein CDw44 and lymphocyte homing receptor are identical molecules.

Authors:  I Stefanová; I Hilgert; V Bazil; H Kristofová; V Horejsí
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

2.  Sialic acid-dependent epitopes of CD45 molecules of restricted cellular expression.

Authors:  V Bazil; I Hilgert; H Kristofová; D Maurer; V Horejsí
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

3.  Gene for human CD59 (likely Ly-6 homologue) is located on the short arm of chromosome 11.

Authors:  U H Forsberg; V Bazil; I Stefanová; J Schröder
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  CD43, the major sialoglycoprotein of human leukocytes, is proteolytically cleaved from the surface of stimulated lymphocytes and granulocytes.

Authors:  V Bazil; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

5.  An alternative way of CD4 and CD8 association with protein kinases of the Src family.

Authors:  T Cinek; I Hilgert; V Horejsí
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression.

Authors:  I Stefanová; M W Saville; C Peters; F R Cleghorn; D Schwartz; D J Venzon; K J Weinhold; N Jack; C Bartholomew; W A Blattner; R Yarchoan; J B Bolen; I D Horak
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

7.  The human leucocyte antigen CD48 (MEM-102) is closely related to the activation marker Blast-1.

Authors:  V Korínek; I Stefanová; P Angelisová; I Hilgert; V Horejsí
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

8.  Stabilization of the CD81 Large Extracellular Loop with De Novo Disulfide Bonds Improves Its Amenability for Peptide Grafting.

Authors:  Stefan Vogt; Gerhard Stadlmayr; Katharina Stadlbauer; Flávio Sádio; Peter Andorfer; Johannes Grillari; Florian Rüker; Gordana Wozniak-Knopp
Journal:  Pharmaceutics       Date:  2018-08-27       Impact factor: 6.525

9.  Novel SAMD9 Mutation in a Patient With Immunodeficiency, Neutropenia, Impaired Anti-CMV Response, and Severe Gastrointestinal Involvement.

Authors:  Renata Formankova; Veronika Kanderova; Marketa Rackova; Michael Svaton; Tomas Brdicka; Petr Riha; Petra Keslova; Ester Mejstrikova; Marketa Zaliova; Tomas Freiberger; Hana Grombirikova; Zuzana Zemanova; Marcela Vlkova; Filip Fencl; Ivana Copova; Jiri Bronsky; Petr Jabandziev; Petr Sedlacek; Jana Soukalova; Ondrej Zapletal; Jan Stary; Jan Trka; Tomas Kalina; Karolina Skvarova Kramarzova; Eva Hlavackova; Jiri Litzman; Eva Fronkova
Journal:  Front Immunol       Date:  2019-09-18       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.